Participant flow

Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer Detection · Source last updated 2019-04-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   prostate adenocarcinoma in pathologic evaluation

   id

   FG000

   title

   Prostate Cancer

2. description

   benign prostatic diseases in pathologic evaluation

   id

   FG001

   title

   Control

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         119

      2. group Id

         FG001

         num Subjects

         361

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         119

      2. group Id

         FG001

         num Subjects

         361

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice